2.445

4.86% -0.125

Cabaletta Bio Inc (CABA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CABA? Forum Prognose

Schlusskurs vom Vortag:

$2.57

Offen:

$2.5

24-Stunden-Volumen:

663.18K

Relative Volume:

0.17

Marktkapitalisierung:

$235.85M

Einnahmen:

Nettoeinkommen (Verlust:

$-67.68M

KGV:

-1.4729

EPS:

-1.66

Netto-Cashflow:

$-54.24M

1W Leistung:

+6.30%

1M Leistung:

-32.27%

6M Leistung:

+30.75%

1J Leistung:

-35.99%

1-Tages-Spanne:

$2.40

$2.505

1-Wochen-Bereich:

$2.115

$2.69

52-Wochen-Spanne:

$0.9857

$5.46

Cabaletta Bio Inc Stock (CABA) Company Profile

Firmenname

Cabaletta Bio Inc

Sektor

Healthcare (1138)

Branche

Biotechnology (638)

Telefon

(267) 759-3100

Adresse

2929 ARCH STREET, PHILADELPHIA, PA

Mitarbeiter

151

Twitter

@CabalettaBio

Nächster Verdiensttermin

2025-03-31

Neueste SEC-Einreichungen

CABA's Discussions on Twitter

Vergleichen Sie CABA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CABA Cabaletta Bio Inc	2.45	247.40M	0	-67.68M	-54.24M	-1.66
VRTX Vertex Pharmaceuticals Inc	426.46	110.02B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	765.12	82.00B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	458.53	59.61B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	890.30	56.15B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	207.51	44.31B	447.02M	-1.18B	-906.14M	-6.1812

Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-10	Fortgesetzt	Jefferies	Buy
2024-12-20	Herabstufung	Evercore ISI	Outperform → In-line
2024-12-19	Herabstufung	Wells Fargo	Overweight → Equal Weight
2024-10-10	Eingeleitet	UBS	Buy
2024-02-05	Eingeleitet	Jefferies	Buy
2023-11-29	Eingeleitet	William Blair	Outperform
2023-10-24	Eingeleitet	Cantor Fitzgerald	Overweight
2023-10-19	Eingeleitet	Stifel	Buy
2023-09-05	Eingeleitet	Citigroup	Buy
2023-07-18	Eingeleitet	Guggenheim	Buy
2023-01-27	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2022-08-30	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-12-08	Eingeleitet	Wells Fargo	Overweight
2021-10-19	Fortgesetzt	Morgan Stanley	Overweight
2021-06-30	Eingeleitet	Mizuho	Buy
2021-01-08	Eingeleitet	Chardan Capital Markets	Buy
2020-10-13	Eingeleitet	H.C. Wainwright	Buy
2019-11-19	Eingeleitet	Cowen	Outperform
2019-11-19	Eingeleitet	Evercore ISI	Outperform
2019-11-19	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Cabaletta Bio Inc Aktie (CABA) Neueste Nachrichten

05:37 AM

Is Cabaletta Bio Inc stock gaining market shareWeekly Trading Summary & Low Risk High Win Rate Picks - BỘ NỘI VỤ

05:37 AM

Nov 30, 2025

Cabaletta Bio Prices Public Offering to Raise $100 Million - MSN

Nov 30, 2025

Nov 21, 2025

Cabaletta Bio to Present at Key Global Healthcare and Immunology Conferences - MSN

Nov 21, 2025

Nov 19, 2025

How supply chain issues affect Cabaletta Bio Inc. stock2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com

Nov 19, 2025

Can Cabaletta Bio Inc. stock maintain operating margins2025 Market Overview & Free Real-Time Volume Trigger Notifications - newser.com

Nov 19, 2025

Will Cabaletta Bio Inc. stock outperform Nasdaq indexQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com

Nov 19, 2025

How Cabaletta Bio Inc. stock reacts to oil pricesJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com

Nov 19, 2025

How Cabaletta Bio Inc. stock performs in rising dollar environmentTrade Risk Assessment & Weekly High Momentum Picks - newser.com

Nov 19, 2025

Nov 18, 2025